Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)
Go back to Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)| Sunshine Biopharma, Inc. (NASDAQ: SBFM) | Delayed: 2.05 -0.08 (3.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.13 | 52 Week High | $0.04 | |||
| Open | $2.06 | 52 Week Low | $0.00 | |||
| Day High | $2.13 | P/E | N/A | |||
| Day Low | $2.03 | EPS | $0.00 | |||
| Volume | 81,431 | |||||
